Market cap
$17 Mln
Revenue (TTM)
$48 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -18.20 | -48.27 | 30.91 | 11.94 | 15.02 |
| EBIT | 43.96 | 75.09 | 28.70 | -27.46 | -202.78 |
| Net Profit | 89.74 | 93.88 | 30.50 | -35.90 | -214.02 |
| EPS | 89.74 | 95.41 | 45.75 | -0.30 | -14.19 |
| Book Value | -- | -- | -61.04 | -26.73 | -12.59 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-22 | Dec-21 | Dec-20 |
| EBIT-Margin
| -59.77 | -47.75 | -42.21 | -65.01 | -72.08 |
| Net Margin
| -- | -23.51 | -- | -- | -- |
| Return on equity
| -99.09 | -75.77 | -89.47 | -109.29 | -98.52 |
| Return on Capital
| -51.58 | -44.22 | -45.22 | -59.85 | -49.66 |
| Return on Assets
| -41.90 | -36.27 | -34.29 | -49.08 | -42.32 |
| Debt to Equity (x)
| -- | -- | 1.41 | 0.75 | 0.91 |
Profitability
ROCE
-45.22
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
-45.22
|
-59.85
|
-49.66
|
-32.83
|
-33.55
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-89.47
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
-89.47
|
-109.29
|
-98.52
|
-47.68
|
-33.90
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-34.29
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
-34.29
|
-49.08
|
-42.32
|
-28.30
|
-27.35
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-42.21
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
-42.21
|
-65.01
|
-72.08
|
-36.58
|
-22.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-48.18
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
-48.18
|
-91.81
|
-83.81
|
-39.68
|
-23.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.31
--
Year on year growth in net sales
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
0.31
|
0.21
|
-0.12
|
0.03
|
0.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
15.01
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
15.01
|
-9.36
|
-74.11
|
-64.91
|
-17.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
31.30
--
Year on year growth in profit after tax
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
31.30
|
-32.84
|
-86.63
|
-73.86
|
-23.45
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.48
--
Year on year growth in earnings per share
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
0.48
|
-0.05
|
-0.67
|
-0.43
|
-0.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.41
--
Total debt / Net worth
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
1.41
|
0.75
|
0.91
|
1.06
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
1.10
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
1.10
|
0.06
|
0.03
|
0.03
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.23
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
1.23
|
3.59
|
3.22
|
5.00
|
4.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
1.04
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
1.04
|
2.74
|
2.20
|
3.51
|
3.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-53.41
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
-53.41
|
-8.24
|
-7.72
|
-33.75
|
-12.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
38.73
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
38.73
|
30.98
|
11.09
|
10.62
|
22.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.71
--
Sales / Average Total Assets
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
0.71
|
0.53
|
0.50
|
0.71
|
1.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
113.96
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
113.96
|
73.29
|
42.21
|
58.48
|
51.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
97.69
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
97.69
|
134.67
|
169.16
|
142.30
|
104.62
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
52.49
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
52.49
|
71.33
|
67.86
|
55.18
|
43.62
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
159.15
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
159.15
|
136.62
|
143.51
|
145.59
|
112.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-0.30
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
-0.30
|
-0.81
|
-3.54
|
-5.67
|
-10.07
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.40
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
0.40
|
0.80
|
3.25
|
3.23
|
2.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.95
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Chembio Diagnostics (CEMI)
|
-0.95
|
-1.16
|
-4.81
|
-7.14
|
-10.48
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|